Influence of type of starch and feeding management

Affect of kind of starch and feeding administration on glycaemic management in diabetic canine

  • The current research evaluated the consequences of two diets with completely different starch sources and two feeding strategies on the glycaemic management in canine with diabetes mellitus. The diets had related nutrient contents (40% starch and 16% dietary fibre), one formulated with 46% of damaged rice and the opposite with 42% sorghum and 10% lentils (as-fed).
  • Ten client-owned diabetic canine had been fed with every weight loss plan for two months, in a crossover design. 5 canine obtained NPH human insulin and meals each 12 h (feeding technique 1), and the opposite 5 obtained insulin each 12 h however had been fed 3 times a day (feeding technique 2). In feeding technique 2, morning insulin was larger than the night dose and canine obtained the second meal after Four to five h of the morning insulin and meal.
  • Parameters evaluated included insulin dosage, 12- and 8-h glycaemic curves, full blood rely, biochemical profile and urinalysis. Glycaemic curves had been analysed by ANOVA with repeated measures. Glycaemic management parameters (fasting, imply, minimal and most glycaemia and serum fructosamine) and glucose space underneath the curve (AUC) had been calculated and analysed by paired t check (p < 0.05). In feeding technique 1, canine fed the sorghum-based weight loss plan offered decrease imply (p = 0.04) and minimal blood glucose concentrations (p = 0.03), and an inclination to decrease most blood glucose (p = 0.06) and glucose AUC (p = 0.08) than when fed the rice-based weight loss plan.
  • When meals was offered twice a day, the ingestion of the rice-based weight loss plan resulted in larger post-prandial glucose response than the weight loss plan with sorghum and lentil. In feeding technique 2, there was no impact of weight loss plan on the assessed parameters (p > 0.05).
  • No variations in insulin dosage had been noticed between teams or feeding strategies (p > 0.05). Offering two meals a day adopted by insulin administration related to the sorghum- and lentil-based weight loss plan improved glycaemic management in diabetic canine.
insuline-medical
insuline-medical

Polyclonal RRAD Antibody

APR05556G 0.1ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAD . This antibody is tested and proven to work in the following applications:

RRAD Conjugated Antibody

C37229 100ul
EUR 476.4

GTP-binding protein RAD (RRAD) Antibody

20-abx241706
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

GTP-binding protein RAD (RRAD) Antibody

20-abx214509
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

GTP-binding protein RAD (RRAD) Antibody

20-abx324872
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

GTP-binding protein RAD (RRAD) Antibody

abx332370-100ul 100 ul
EUR 510

GTP-Binding Protein RAD (RRAD) Antibody

abx432011-200ul 200 ul
EUR 460.8

GTP-Binding Protein RAD (RRAD) Antibody

20-abx008742
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Rrad/ Rat Rrad ELISA Kit

ELI-14921r 96 Tests
EUR 1063.2

RRAD And GEM Like GTPase 2 (REM2) Antibody

abx237237-100ug 100 ug
EUR 661.2

RRAD And GEM Like GTPase 2 (REM2) Antibody

abx122938-100ug 100 ug
EUR 469.2

RRAD siRNA

20-abx932133
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

Polyclonal RRAD (aa36-48) Antibody (internal region)

APG00807G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human RRAD (aa36-48) (internal region). This antibody is tested and proven to work in the following applications:

RRAD Peptide

43-008P 0.1 mg
EUR 405.6
Description: RRAD Peptide

RRAD Blocking Peptide

20-abx063234
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

RRAD Blocking Peptide

33R-10070 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5798

RRAD Blocking Peptide

33R-4793 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5797

RRAD ELISA KIT|Human

EF005507 96 Tests
EUR 826.8

Human RRAD shRNA Plasmid

20-abx954199
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

RRAD Recombinant Protein (Rat)

RP226925 100 ug Ask for price

RRAD Recombinant Protein (Mouse)

RP169340 100 ug Ask for price

RRAD Recombinant Protein (Human)

RP095493 100 ug Ask for price

Rrad ORF Vector (Rat) (pORF)

ORF075643 1.0 ug DNA
EUR 607.2

RRAD ORF Vector (Human) (pORF)

ORF031832 1.0 ug DNA
EUR 486

Rrad ORF Vector (Mouse) (pORF)

ORF056448 1.0 ug DNA
EUR 607.2

Rrad sgRNA CRISPR Lentivector set (Rat)

K7052701 3 x 1.0 ug
EUR 406.8

Rrad 3'UTR GFP Stable Cell Line

TU168183 1.0 ml Ask for price

RRAD 3'UTR GFP Stable Cell Line

TU072380 1.0 ml
EUR 1672.8

Rrad 3'UTR GFP Stable Cell Line

TU269725 1.0 ml Ask for price

Rrad sgRNA CRISPR Lentivector set (Mouse)

K3480701 3 x 1.0 ug
EUR 406.8

RRAD sgRNA CRISPR Lentivector set (Human)

K2069901 3 x 1.0 ug
EUR 406.8

RRAD Protein Vector (Rat) (pPM-C-HA)

PV302572 500 ng
EUR 723.6

RRAD Protein Vector (Rat) (pPB-C-His)

PV302570 500 ng
EUR 723.6

RRAD Protein Vector (Rat) (pPB-N-His)

PV302571 500 ng
EUR 723.6

RRAD Protein Vector (Rat) (pPM-C-His)

PV302573 500 ng
EUR 723.6

RRAD Protein Vector (Human) (pPM-C-HA)

PV127328 500 ng
EUR 662.4

RRAD Protein Vector (Mouse) (pPM-C-HA)

PV225792 500 ng
EUR 723.6

RRAD Protein Vector (Human) (pPB-C-His)

PV127326 500 ng
EUR 662.4

RRAD Protein Vector (Human) (pPB-N-His)

PV127327 500 ng
EUR 662.4

RRAD Protein Vector (Human) (pPM-C-His)

PV127329 500 ng
EUR 662.4

RRAD Protein Vector (Mouse) (pPB-C-His)

PV225790 500 ng
EUR 723.6

RRAD Protein Vector (Mouse) (pPB-N-His)

PV225791 500 ng
EUR 723.6

RRAD Protein Vector (Mouse) (pPM-C-His)

PV225793 500 ng
EUR 723.6

Rrad 3'UTR Luciferase Stable Cell Line

TU118183 1.0 ml Ask for price

RRAD 3'UTR Luciferase Stable Cell Line

TU022380 1.0 ml
EUR 1672.8

Rrad 3'UTR Luciferase Stable Cell Line

TU219725 1.0 ml Ask for price

Rrad sgRNA CRISPR Lentivector (Rat) (Target 1)

K7052702 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Rat) (Target 2)

K7052703 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Rat) (Target 3)

K7052704 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3480702 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3480703 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3480704 1.0 ug DNA
EUR 184.8

RRAD sgRNA CRISPR Lentivector (Human) (Target 1)

K2069902 1.0 ug DNA
EUR 184.8

RRAD sgRNA CRISPR Lentivector (Human) (Target 2)

K2069903 1.0 ug DNA
EUR 184.8

RRAD sgRNA CRISPR Lentivector (Human) (Target 3)

K2069904 1.0 ug DNA
EUR 184.8

Rat GTP-binding protein RAD (RRAD) ELISA Kit

abx391893-96tests 96 tests
EUR 1093.2

Human GTP- binding protein RAD, RRAD ELISA KIT

ELI-35549h 96 Tests
EUR 988.8

Mouse GTP- binding protein RAD, Rrad ELISA KIT

ELI-14089m 96 Tests
EUR 1038

Mouse GTP-binding protein RAD (RRAD) ELISA Kit

abx390415-96tests 96 tests
EUR 1093.2

Human GTP-binding protein RAD (RRAD) ELISA Kit

abx385354-96tests 96 tests
EUR 1093.2

RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV658369 1.0 ug DNA
EUR 616.8

RRAD Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV658373 1.0 ug DNA
EUR 616.8

RRAD Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV658374 1.0 ug DNA
EUR 616.8

Human RRAD And GEM Like GTPase 2 (REM2) ELISA Kit

abx382769-96tests 96 tests
EUR 1093.2

Anti-RRAD (aa36-48) antibody

STJ72757 100 µg
EUR 430.8

Rrad ELISA Kit| Rat GTP-binding protein RAD ELISA Kit

EF019253 96 Tests
EUR 826.8

Rrad ELISA Kit| Mouse GTP-binding protein RAD ELISA Kit

EF016057 96 Tests
EUR 826.8

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K7052705 3 x 1.0 ug
EUR 451.2

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3480705 3 x 1.0 ug
EUR 451.2

RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K2069905 3 x 1.0 ug
EUR 451.2

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K7052706 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K7052707 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K7052708 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3480706 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3480707 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3480708 1.0 ug DNA
EUR 200.4

RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K2069906 1.0 ug DNA
EUR 200.4

RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K2069907 1.0 ug DNA
EUR 200.4

RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K2069908 1.0 ug DNA
EUR 200.4

RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV658370 1.0 ug DNA
EUR 616.8

RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV658371 1.0 ug DNA
EUR 686.4

RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV658372 1.0 ug DNA
EUR 686.4

RRAGA / RRAGB Antibody

abx332724-100ul 100 ul
EUR 510

RRAGA / RRAGB Antibody

20-abx328592
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

RRAGA/RRAGB Antibody

1-CSB-PA003930
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against RRAGA/RRAGB. Recognizes RRAGA/RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

RRAGA/RRAGB Antibody

CSB-PA590465- each
EUR 402
Description: A polyclonal antibody against RRAGA/RRAGB. Recognizes RRAGA/RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

RRAGA/RRAGB Antibody

CSB-PA590465-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against RRAGA/RRAGB. Recognizes RRAGA/RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

RRAS Antibody

37881-100ul 100ul
EUR 302.4

RRAS antibody

70R-20022 50 ul
EUR 522
Description: Rabbit polyclonal RRAS antibody

RRAS Antibody

1-CSB-PA020513GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against RRAS. Recognizes RRAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

RRAS Antibody

1-CSB-PA444135
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAS. Recognizes RRAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

RRAS Antibody

1-CSB-PA663638
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAS. Recognizes RRAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100

RRAGC antibody

10R-1679 100 ug
EUR 614.4
Description: Mouse monoclonal RRAGC antibody

RRAGA Antibody

40326-100ul 100ul
EUR 302.4

RRAGC Antibody

40327-100ul 100ul
EUR 302.4

RRAS2 Antibody

40328-100ul 100ul
EUR 302.4

RRAS2 Antibody

7249-002mg 0.02 mg
EUR 206.18
Description: RRAS2 Antibody: Activating mutations and overexpression of classical Ras subfamily members (K-RAS, N-RAS and H-RAS) have been widely investigated as key events in the development of human cancers. The RRAS subfamily of Ras-related proteins includes RRAS1, RRAS2 (TC21) and RRAS3 (M-Ras) show overall amino acid identity with the classical Ras subfamily (H-Ras, K-Ras and N-Ras) of 55–60%. RRAS2 is a small GTPbinding protein of the Ras superfamily of GTPases. It might transduce growth inhibitory signals across the cell membrane, exerting its effect through an effector shared with the Ras proteins. RRAS2 has high oncogenic potential and overexpression/mutations have been reported in several tumor tissues and cell lines.

RRAS2 Antibody

7249-01mg 0.1 mg
EUR 523.7
Description: RRAS2 Antibody: Activating mutations and overexpression of classical Ras subfamily members (K-RAS, N-RAS and H-RAS) have been widely investigated as key events in the development of human cancers. The RRAS subfamily of Ras-related proteins includes RRAS1, RRAS2 (TC21) and RRAS3 (M-Ras) show overall amino acid identity with the classical Ras subfamily (H-Ras, K-Ras and N-Ras) of 55–60%. RRAS2 is a small GTPbinding protein of the Ras superfamily of GTPases. It might transduce growth inhibitory signals across the cell membrane, exerting its effect through an effector shared with the Ras proteins. RRAS2 has high oncogenic potential and overexpression/mutations have been reported in several tumor tissues and cell lines.

RRAGA antibody

70R-15303 100 ug
EUR 392.4
Description: Rabbit polyclonal RRAGA antibody

RRAGB antibody

70R-20021 50 ul
EUR 522
Description: Rabbit polyclonal RRAGB antibody

RRAS2 antibody

70R-20023 50 ul
EUR 522
Description: Rabbit polyclonal RRAS2 antibody

RRAGD antibody

70R-3629 50 ug
EUR 560.4
Description: Rabbit polyclonal RRAGD antibody raised against the middle region of RRAGD

RRAGC antibody

70R-3630 50 ug
EUR 560.4
Description: Rabbit polyclonal RRAGC antibody raised against the N terminal of RRAGC

RRAS2 antibody

70R-50868 100 ul
EUR 292.8
Description: Purified Polyclonal RRAS2 antibody

RRAGD Antibody

46175-100ul 100ul
EUR 302.4

RRAGD Antibody

46175-50ul 50ul
EUR 224.4

RRAGC Antibody

ABD13245 100 ug
EUR 525.6

RRAGB Antibody

ABD4393 100 ug
EUR 525.6

RRAGC Antibody

ABD4394 100 ug
EUR 525.6

RRAGA Antibody

ABD7957 100 ug
EUR 525.6

Associations between attainment of incentivized main care indicators and incident decrease limb amputation amongst these with kind 2 diabetes: a population-based historic cohort research

Introduction: England has invested significantly in diabetes care by way of such packages because the High quality and Outcomes Framework (QOF) and Nationwide Diabetes Audit (NDA). Associations between program indicators and scientific endpoints, similar to amputation, stay unclear. We examined associations between main care indicators and incident decrease limb amputation.

Analysis design and strategies: This population-based retrospective cohort research, spanning 2010-2017, was comprised of adults in England with kind 2 diabetes and no historical past of decrease limb amputation. Exposures at baseline (2010-2011) had been attainment of QOF glycated hemoglobin (HbA1c), blood stress and whole ldl cholesterol indicators, and variety of NDA processes accomplished.

Propensity rating matching was carried out and multivariable Cox proportional hazards fashions, adjusting for disease-related, comorbidity, way of life, and sociodemographic elements, had been fitted utilizing matched samples for every publicity.

Outcomes: 83 688 people from 330 English main care practices had been included. Imply follow-up was 3.9 (SD 2.0) years, and 521 (0.6%) minor or main amputations had been noticed (1.62 per 1000 person-years). HbA1c and ldl cholesterol indicator attainment had been related to significantly decrease dangers of minor or main amputation (adjusted HRs; 95% CIs) 0.61 (0.49 to 0.74; p<0.0001) and 0.67 (0.53 to 0.86; p=0.0017), respectively). No proof of affiliation between blood stress indicator attainment and amputation was noticed (adjusted HR 0.88 (0.73 to 1.06; p=0.1891)).

Considerably decrease amputation charges had been noticed amongst these finishing a larger variety of NDA care processes (adjusted HRs 0.45 (0.24 to 0.83; p=0.0106), 0.67 (0.47 to 0.97; p=0.0319), and 0.38 (0.20 to 0.70; p=0.0022) for comparisons of 4-6 vs 0-3, 7-9 vs 0-3, and 7-9 vs 4-6 processes, respectively). Outcomes for major-only amputations had been related for HbA1c and blood stress, although ldl cholesterol indicator attainment was non-significant.

Conclusions: Complete main care-based secondary prevention might supply appreciable safety in opposition to diabetes-related amputation. This has necessary implications for diabetes administration and medical decision-making for sufferers, in addition to kind 2 diabetes high quality enchancment packages.

 

The pattern-recognition molecule H-ficolin in relation to diabetic kidney illness, mortality, and cardiovascular occasions in kind 1 diabetes

H-ficolin acknowledges patterns on microorganisms and burdened cells and may activate the lectin pathway of the complement system. We aimed to evaluate H-ficolin in relation to the development of diabetic kidney illness (DKD), all-cause mortality, diabetes-related mortality, and cardiovascular occasions.

Occasion charges per 10-unit H-ficolin-increase had been in contrast in an observational follow-up of two,410 people with kind 1 diabetes from the FinnDiane Research. DKD development occurred in 400 people. The unadjusted hazard ratio (HR) for development was 1.29 (1.18-1.40) and 1.16 (1.05-1.29) after adjustment for diabetes length, intercourse, HbA1c, systolic blood stress, and smoking standing.

After including triglycerides to the mannequin, the HR decreased to 1.07 (0.97-1.18). In all, 486 people died, together with 268 deaths of cardiovascular causes and 192 deaths of problems to diabetes. HRs for all-cause mortality and cardiovascular mortality had been 1.13 (1.04-1.22) and 1.05 (0.93-1.17), respectively, in unadjusted analyses. These estimates misplaced statistical significance in adjusted fashions.

Nevertheless, the unadjusted HR for diabetes-related mortality was 1.19 (1.05-1.35) and 1.18 (1.02-1.37) with probably the most stringent adjustment stage. Our outcomes, due to this fact, point out that H-ficolin predicts diabetes-related mortality, however neither all-cause mortality nor deadly/non-fatal cardiovascular occasions. Moreover, H-ficolin is related to DKD development, nevertheless, not independently of the totally adjusted mannequin.

The worth of glycosylated hemoglobin within the prognosis of diabetic retinopathy: a scientific evaluate and Meta-analysis

 Goal: Glycosylated hemoglobin (HbA1c) has apparent scientific worth within the prognosis of diabetes, however the conclusions on the diagnostic worth of diabetic retinopathy (DR) should not constant. This research goals to comprehensively consider the accuracy of glycosylated hemoglobin within the prognosis of diabetic retinopathy by way of the meta-analysis of diagnostic checks.

Strategies: Cochrane Library, Embase, PubMed, Net of Science, China Nationwide Information Infrastructure (CNKI), China Wanfang Database, Chinese language Biomedical Literature Database (CBM) had been searched till November, 2020. The High quality Evaluation of Diagnostic Accuracy Research-2 (QUADAS-2) software was used to evaluate the standard of the included research. The pooled sensitivity, specificity, optimistic probability ratio (+LR), unfavourable probability ratio (-LR), diagnostic odds ratio (DOR) and areas underneath the receiver working attribute (ROC) curve had been calculated by Stata 15.Zero software program.

Outcomes: After screening, 18 high-quality papers had been included. The outcomes of meta-analysis confirmed that the mixed DOR = 18.19 (95% CI: 10.99-30.11), the sensitivity= 0.81 (95% CI): 0.75 ~ 0.87), specificity = 0.81 (95%CI: 0.72 ~ 0.87), +LR = 4.2 (95%CI: 2.95 ~ 6.00), -LR = 0.23 (95%CI: 0.17 ~ 0.31), and the world underneath the Abstract ROC curve was 0.88 (95%CI: 0.85 ~ 0.90).

Conclusion: The general accuracy of HbA1cC forin diagnosing diabetic retinopathy is sweet. As it’s extra secure than blood sugar and isn’t affected by meals, it might be an acceptable indicator for diabetic retinopathy.

Exosome Component 2 (EXOSC2) Antibody

abx034983-400ul 400 ul
EUR 627.6

Exosome Component 2 (EXOSC2) Antibody

abx034983-80l 80 µl
EUR 343.2

Exosome Component 2 (EXOSC2) Antibody

20-abx125830
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Exosome Component 2 (EXOSC2) Antibody

20-abx003412
  • EUR 493.20
  • EUR 710.40
  • 100 ul
  • 200 ul

Exosome Isolation kit (for serum & plasma -Exosome-RNA-NGS)

P101NGS - Ask for price

Lung Cancer Exosome

P141-LG - Ask for price

Leukemia - ALL Exosome

P141-ALL - Ask for price

Leukemia - AML Exosome

P141-AML - Ask for price

Leukemia - CLL Exosome

P141-CLL - Ask for price

Leukemia - CML Exosome

P141-CML - Ask for price

Liver Cancer Exosome

P141-LV - Ask for price

Breast Cancer Exosome

P141-BR - Ask for price

Crohn's Disease Exosome

P141-CR - Ask for price

Kidney Cancer Exosome

P141-KN - Ask for price

Psoriasis Exosome RNA

P241-PS - Ask for price

Bladder Cancer Exosome

P141-BL - Ask for price

Thyroid Cancer Exosome

P141-TH - Ask for price

Human Exosome Component 2 (EXOSC2) Protein

20-abx653328
  • EUR 693.60
  • EUR 309.60
  • EUR 2064.00
  • EUR 828.00
  • EUR 510.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Prostate Cancer Exosome

P141-PR - Ask for price

Colorectal Cancer Exosome

P141-CO - Ask for price

Human Exosome Component 2 (EXOSC2) CLIA Kit

20-abx495555
  • EUR 9567.60
  • EUR 5095.20
  • EUR 1177.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Lung Cancer Exosome RNA

P241-LG - Ask for price

Human Exosome Component 2 (EXOSC2) ELISA Kit

20-abx151457
  • EUR 8853.60
  • EUR 4719.60
  • EUR 1093.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Exosome Component 2 (EXOSC2)ELISA Kit

201-12-2689 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

DLR-EXOSC2-Hu-48T 48T
EUR 620.4
Description: A sandwich quantitative ELISA assay kit for detection of Human Exosome Component 2 (EXOSC2) in samples from tissue homogenates, cell lysates or other biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

DLR-EXOSC2-Hu-96T 96T
EUR 807.6
Description: A sandwich quantitative ELISA assay kit for detection of Human Exosome Component 2 (EXOSC2) in samples from tissue homogenates, cell lysates or other biological fluids.

Human Exosome Component 2 ELISA Kit (EXOSC2)

RK01330 96 Tests
EUR 625.2

Human Exosome Component 2 (EXOSC2) ELISA Kit

RDR-EXOSC2-Hu-48Tests 48 Tests
EUR 652.8

Human Exosome Component 2 (EXOSC2) ELISA Kit

RDR-EXOSC2-Hu-96Tests 96 Tests
EUR 907.2

Human Exosome Component 2(EXOSC2)ELISA Kit

QY-E01130 96T
EUR 433.2

Human Exosome Component 2 (EXOSC2) ELISA Kit

RD-EXOSC2-Hu-48Tests 48 Tests
EUR 625.2

Human Exosome Component 2 (EXOSC2) ELISA Kit

RD-EXOSC2-Hu-96Tests 96 Tests
EUR 867.6

Human Exosome Component 2 (EXOSC2) ELISA Kit

SEH822Hu-10x96wellstestplate 10x96-wells test plate
EUR 5677.8
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Exosome Component 2 (EXOSC2) in Tissue homogenates, cell lysates and other biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

SEH822Hu-1x48wellstestplate 1x48-wells test plate
EUR 572.76
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Exosome Component 2 (EXOSC2) in Tissue homogenates, cell lysates and other biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

SEH822Hu-1x96wellstestplate 1x96-wells test plate
EUR 766.8
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Exosome Component 2 (EXOSC2) in Tissue homogenates, cell lysates and other biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

SEH822Hu-5x96wellstestplate 5x96-wells test plate
EUR 3090.6
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Exosome Component 2 (EXOSC2) in Tissue homogenates, cell lysates and other biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

4-SEH822Hu
  • EUR 5738.40
  • EUR 3031.20
  • EUR 768.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Exosome Component 2 (EXOSC2) in samples from Tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species.

Human Exosome Component 2 (EXOSC2) ELISA Kit

RD-EXOSC2-Hu-48T 48T
EUR 452.7
Description: tissue homogenates, cell lysates and other biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

RD-EXOSC2-Hu-96T 96T
EUR 646.7
Description: tissue homogenates, cell lysates and other biological fluids.

Human Exosome Component 2 (EXOSC2)ELISA Kit

YLA3329HU-48T 48T
EUR 435

Human Exosome Component 2 (EXOSC2)ELISA Kit

YLA3329HU-96T 96T
EUR 562.5

Human Exosome Component 2 (EXOSC2) ELISA Kit

RDR-EXOSC2-Hu-48T 48T
EUR 475.34
Description: tissue homogenates, cell lysates and other biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

RDR-EXOSC2-Hu-96T 96T
EUR 679.04
Description: tissue homogenates, cell lysates and other biological fluids.

Normal human exosome RNA

P240 - Ask for price

Leukemia - ALL Exosome RNA

P241-ALL - Ask for price

Leukemia - AML Exosome RNA

P241-AML - Ask for price

Leukemia - CLL Exosome RNA

P241-CLL - Ask for price

Leukemia - CML Exosome RNA

P241-CML - Ask for price

Liver Cancer Exosome RNA

P241-LV - Ask for price

Exosome-TEM-easy Kit

P130 - Ask for price

Rheumatoid Arthritis Exosome

P141-RA - Ask for price

Exosome isolation Solution - Serum/ Plasma (easy version of P101, 95% pure exosome)

P101EZ - Ask for price

Breast Cancer Exosome RNA

P241-BR - Ask for price

Crohn's Disease Exosome RNA

P241-CR - Ask for price

Kidney Cancer Exosome RNA

P241-KN - Ask for price

Lyophilized Exosome Standards

ExoA375 100 μg
EUR 364.2

Lyophilized Exosome Standards

ExoHT29 100 μg
EUR 364.2

Lyophilized Exosome Standards

ExoMCF7 100 μg
EUR 364.2

Lyophilized Exosome Standards

ExoPC3 100 μg
EUR 364.2

Lyophilized Exosome Standards

ExoPLASMA 100 μg
EUR 364.2

Lyophilized Exosome Standards

ExoUrine 100 μg
EUR 364.2

Nasopharyngeal Cancer Exosome

P141-NA - Ask for price

Exosome precipitation Solution

EPStep 12 ml
EUR 333

Bladder Cancer Exosome RNA

P241-BL - Ask for price

Thyroid Cancer Exosome RNA

P241-TH - Ask for price

Leukemia - Hairy Cell Exosome

P141-HC - Ask for price

Prostate Cancer Exosome RNA

P241-PR - Ask for price

Exosome Component 5 Protein

20-abx260873
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 25 ug
  • 5 ug

Exosome Component 7 Protein

20-abx261347
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

Exosome Component 10 Protein

20-abx261805
  • EUR 5238.00
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

Exosome Component 4 Protein

20-abx261954
  • EUR 5388.00
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

Exosome Component 9 Protein

20-abx262123
  • EUR 393.60
  • EUR 6106.80
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

Exosome Component 8 Protein

20-abx262850
  • EUR 393.60
  • EUR 7676.40
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

Exosome Component 3 Protein

20-abx263422
  • EUR 276.00
  • EUR 1930.80
  • EUR 393.60
  • 1 µg
  • 50 ug
  • 5 ug

Exosome Component 1 Protein

20-abx263423
  • EUR 1930.80
  • EUR 393.60
  • EUR 276.00
  • 100 ug
  • 10 ug
  • 2 µg

Exosome Component 9 Peptide

46-967P 0.1 mg
EUR 405.6
Description: (CT) PMSCL1 Peptide

Melanoma (skin cancer) Exosome

P141-MN - Ask for price

Exosome isolation Solution - Cell Media/ Urine (easy version of P100, 95% pure exosome)

P100EZ - Ask for price

Uterine Corpus Cancer Exosome

P141-UT - Ask for price

Colorectal Cancer Exosome RNA

P241-CO - Ask for price

EXOCET Exosome Quantitation Kit

EXOCET96A-1 96 reactions
EUR 462

Exo-APC Exosome FACS stain

EXOFLOW810A-1 20 reactions
EUR 188

ELISA kit for Human EXOSC2 (Exosome Component 2)

ELK4639 1 plate of 96 wells
EUR 518.4
Description: A sandwich ELISA kit for detection of Exosome Component 2 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Exosome isolation Solution - Serum/ Plasma (easy version of P101, 95% pure exosome) sample

P101EZ--sample - Ask for price

Non-Hodgkin lymphoma Exosome

P141-NH - Ask for price

Exo-FITC Exosome FACS stain

EXOFLOW800A-1 20 reactions
EUR 188

Uterine Cervical Cancer Exosome

P141-UC - Ask for price

Exosome Component 2 (EXOSC2) Polyclonal Antibody (Human)

4-PAH822Hu01
  • EUR 296.40
  • EUR 3012.00
  • EUR 750.00
  • EUR 372.00
  • EUR 256.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Exosome Component 2 (EXOSC2)

Rheumatoid Arthritis Exosome RNA

P241-RA - Ask for price

Leukemia - Multiple Myeloma Exosome

P141-MM - Ask for price

 

, , , , , , , , , , , , , ,

Post navigation

Leave a Reply

Your email address will not be published. Required fields are marked *